Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS (Details Narrative)

v3.22.2.2
STOCK OPTIONS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Stock option intrinsic value $ 26 $ 26   $ 107,000
Stock option granted   2,689,555    
Stock option weighted average exercise price   $ 1.07    
Option, exercised   332,730    
Proceeds from option exercise   $ 377,000 $ 377,000  
Common Stock [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Option, exercised   332,730 332,730  
Shares issued, shares   332,730    
Employees and Consultants [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Stock option granted   2,689,555    
Stock option weighted average exercise price   $ 1.07    
Stock option grant date fair value   $ 2,596,000    
Stock option plan expense 374,000 905,000    
Unrecognized share-based compensation expense $ 3,022,000 $ 3,022,000